Share

This deal is 'very positive' for the US: Pfizer CEO

Pfizer CEO Ian Read and Allergan CEO Brent Saunders discuss their $160 billion merger and the resulting pharmaceutical powerhouse.
06:31
Mon, Nov 23 201510:00 AM EST